[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100521160":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":12,"locations":18,"responsibleParty":47,"collaborators":49,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":91,"sex":97,"minAge":98,"maxAge":7,"enrollmentInfo":99,"targetDuration":102,"studyType":103,"phases":7,"briefSummary":104,"conditions":105,"keywords":7,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"Universitair Ziekenhuis Brussel","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Questionnaires","Health-related quality of life will be measured using the 12-item Short Form (SF-12) and EQ5D-5L questionnaires. The SF-12 is summarized into two component scores, the Physical Component Score (PCS) and Mental Composite Score (MCS).",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Karlien François, MD PhD","CONTACT","+324776055","Karlien.Francois@uzbrussel.be",[19,33],{"facility":5,"status":20,"city":21,"state":7,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"RECRUITING","Brussels","1090","Belgium","BE",{"type":26,"coordinates":27},"Point",[28,29],4.34878,50.85045,{"lat":29,"lon":28},[32],{"name":14,"role":15,"phone":7,"phoneExt":7,"email":17},{"facility":34,"status":20,"city":35,"state":7,"zip":7,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":42,"contacts":43},"UMC Utrecht","Utrecht","Netherlands","NL",{"type":26,"coordinates":39},[40,41],5.12222,52.09083,{"lat":41,"lon":40},[44],{"name":45,"role":15,"phone":7,"phoneExt":7,"email":46},"Alferso C Abrahams, MD PhD","A.C.Abrahams@umcutrecht.nl",{"type":48,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[50,51,53,55,57,59,61,64,66,68,70,72,74,76,78,80,82,85,87],{"name":34,"class":6},{"name":52,"class":6},"Leiden University Medical Center",{"name":54,"class":6},"Bravis Hospital",{"name":56,"class":6},"Erasme University Hospital",{"name":58,"class":6},"University Hospital, Antwerp",{"name":60,"class":6},"Cliniques universitaires Saint-Luc- Université Catholique de Louvain",{"name":62,"class":63},"az Glorieux","UNKNOWN",{"name":65,"class":6},"Imelda Hospital, Bonheiden",{"name":67,"class":6},"Centre Hospitalier Régional de la Citadelle",{"name":69,"class":6},"Rijnstate Hospital",{"name":71,"class":6},"Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)",{"name":73,"class":6},"HagaZiekenhuis",{"name":75,"class":6},"Bernhoven Hospital",{"name":77,"class":6},"Isala",{"name":79,"class":6},"Deventer Ziekenhuis",{"name":81,"class":63},"Medisch Centrum Leeuwarden",{"name":83,"class":84},"OLVG","NETWORK",{"name":86,"class":6},"Centro Hospitalar Universitario do Algarve",{"name":88,"class":6},"University Medical Centre Ljubljana","100521160","percutaneous-peritoneal-dialysis-catheter-insertion-predict-100521160",false,"NCT06065982","Percutaneous Peritoneal Dialysis Catheter Insertion (PREDICT)","Prospective Observational Cohort Study on the Outcomes of Percutaneous Inserted PD Catheters","PREDICT","Inclusion Criteria:\n\n* Age \\> 18 years\n* Percutaneous PD catheter insertion between March 1st 2023 and March 1st 2026 Patients can be included 4 weeks before until 12 weeks after PD catheter insertion\n\nExclusion Criteria:\n\n* Inability to provide informed consent\n* Life expectancy \\\u003C 3 months","ALL","18 Years",{"count":100,"type":101},500,"ESTIMATED","1 Year","OBSERVATIONAL","Peritoneal dialysis (PD) is the most frequent modality of home dialysis for patients with kidney failure.\n\nMost PD catheters are placed using a laparoscopic technique. This approach requires the availability of a qualified surgeon, time in the operating theater and general anaesthesia for the patient. Thus, the laparoscopic technique is less suitable for patients with severe heart failure or multimorbidity where general anaesthesia is not possible.\n\nPD catheters can also be inserted using a percutaneous strategy using a modified Seldinger technique. This strategy can be performed bedside under local anaesthesia, by the nephrologist, radiologist, a surgeon, physician assistant or qualified nurse.\n\nThe availability of the percutaneous implantation strategy of a PD catheter in a nephrology center may accomodate more patients to receive a PD catheter insertion, including those who have a contraindication to general anaesthesia or need urgent PD.\n\nThe PREDICT project aims to increase knowledge and competencies on percutaneous PD catheter insertions by training centers for this technique. By establisching a prospective registry, the outcomes of percutaneously inserted PD catheters, both in experienced and newly trained centers, will be assessed.",[106],"End-stage Kidney Disease","2023-09-29",{"date":109,"type":110},"2023-10-04","ACTUAL",{"date":112,"type":110},"2023-06-23",{"date":114,"type":101},"2027-06-23",{"name":5,"class":6},2]